Latest News

Chipotle continued its turnaround with another quarter of positive same-store sales growth.

Traeger (NYSE:COOK) reported a 40% decline in third-quarter revenue as lower grill sales, channel changes and pressure on its MEATER business weighed on results. The company narrowed its full-year revenue and adjusted EBITDA outlooks while maintaining the midpoint of each range. Management said it

Cencora (NYSE:COR) reported higher fiscal fourth-quarter revenue and adjusted earnings as specialty drug sales and its acquisition of OneOncology contributed to growth. The company also introduced a new reporting structure that separates its specialty operations from its broader pharmaceutical distr

Tigo Energy (NASDAQ:TYGO) lowered its full-year revenue outlook after third-quarter sales declined 21.5% from a year earlier, as a slower European solar recovery, weaker-than-expected storage adoption and the timing of a U.S. partner’s product launch weighed on results. The solar technology company

AMC Entertainment (NYSE:AMC) reported record third-quarter revenue and adjusted EBITDA as a stronger box office, higher attendance and demand for premium screens helped the theater operator return to a quarterly profit. Revenue rose 31.6% from a year earlier to $1.711 billion, while net earnings we

Amcor (NYSE:AMCR) lowered its adjusted earnings outlook for its six-month transition period as rising energy and distribution costs outpaced its ability to pass those expenses on to customers, even as the packaging company reported organic volume growth for the quarter ended September 30, 2026. The

Compass Diversified (NYSE:CODI) reported higher third-quarter adjusted earnings from its subsidiaries and narrowed its full-year outlook, as growth in its consumer businesses helped offset weaker industrial results. Subsidiary adjusted EBITDA rose 12.9% to approximately $90 million on a comparable

Agilon Health (NYSE:AGL) raised its full-year 2026 outlook after reporting third-quarter results that exceeded its guidance, driven by higher risk-adjustment revenue, clinical program performance and favorable medical cost development in the first half of the year. The company reported third-quarte

TWFG (NASDAQ:TWFG) reported 24.6% revenue growth in the third quarter of 2026 as its managing general agency business expanded and new business premiums rose, even as insurance pricing softened in some markets. Revenue rose to $79.9 million, while organic revenue increased 16.6% to $68.7 million. T

a.k.a. Brands (NYSE:AKA) reported third-quarter sales growth of 9.7% as gains in the U.S. and U.K. helped offset continued declines in Australia and New Zealand. The fashion retailer also expanded its gross margin despite higher freight costs, which management expects to remain a drag on fourth-quar

Chip stocks have normally risen after midterm votes. But how many of those years began like this one?

The numbers would normally be reversed. Let's look at what's got investors thinking so defensively right now.

TaskUs (NASDAQ:TASK) reported record third-quarter revenue and raised its full-year outlook, as growth in artificial intelligence services and customer experience work offset a decline in business from its largest client. Revenue rose 5.4% from a year earlier to $314.7 million, exceeding the top en

SiTime (NASDAQ:SITM) reported third-quarter revenue of $298.7 million, up 257% from a year earlier, as growth in its core timing business and the first full quarter of contributions from an acquired Renesas division pushed its annualized revenue run rate above $1 billion. The company forecast fourt

STAAR Surgical (NASDAQ:STAA) reported lower third-quarter sales and profit on a reported basis, but said revenue rose 21% after excluding a prior-year deferred sales item in China. The implantable lens maker also said demand for higher-priced products in China exceeded its ability to supply them dur

Silvaco Group (NASDAQ:SVCO) forecast record fourth-quarter revenue and mid-to-high teens revenue growth in 2027, as a major customer win helped drive third-quarter bookings for its technology computer-aided design products to a quarterly record. The company reported third-quarter revenue of $16.3 m

Revolution Medicines (NASDAQ:RVMD) reported $197.6 million in third-quarter net product revenue from its newly approved pancreatic cancer treatment RASONQUE, reflecting roughly five weeks of U.S. sales and treatment of more than 5,000 commercial patients. Executives cautioned that the initial sales

Root (NASDAQ:ROOT) reported a profit in the third quarter of 2026 even as revenue and premiums declined, with executives saying they held back spending on direct customer acquisition amid intensifying competition in personal auto insurance. The insurer generated $381 million in revenue, down from $

Rapid7 (NASDAQ:RPD) reported third-quarter annual recurring revenue above its guidance and reaffirmed its full-year cash flow outlook, but executives cautioned that stability in its core cybersecurity business has not yet translated into sustained growth. The company ended the quarter with $820 mil

Sunrun (NASDAQ:RUN) narrowed its full-year 2026 Cash Generation and subscriber value forecasts to the low ends of their previous ranges, citing installation volumes that have lagged its expectations and sustained higher interest rates. The residential solar and battery company now expects approxima

OPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale of BioReference assets to Labcorp. The transaction, announced Oct. 15, would provide approximately

Outset Medical (NASDAQ:OM) reported third-quarter 2026 revenue of $33.6 million, up 14% from a year earlier, as sales of its Tablo dialysis consoles increased and recurring revenue grew. The company reiterated its full-year revenue guidance of $125 million to $130 million. Revenue also rose 6% sequ

PROCEPT BioRobotics (NASDAQ:PRCT) reported 18% revenue growth in the third quarter of 2026 as demand for its HYDROS systems and procedure-related products helped offset slower-than-expected placements at new U.S. accounts. The company maintained its full-year revenue outlook and said it expects to

Sight Sciences (NASDAQ:SGHT) raised its full-year revenue outlook after reporting record third-quarter sales, driven by growth in its glaucoma business and increased adoption of its TearCare dry eye treatment. Revenue for the quarter ended September 30, 2026, rose 25% from a year earlier to $24.9 m

Woodside Energy Group (NYSE:WDS) outlined a new shareholder distribution policy and capital allocation framework at its 2026 Capital Markets Day, as the energy producer targets higher returns from major oil and liquefied natural gas projects. Chief Executive Officer and Managing Director Liz Westco